You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
艾迪藥業(688488.SH)與天普生化簽署採購合同
格隆匯 12-23 15:46

格隆匯 12 月 23日丨艾迪藥業(688488.SH)公佈,公司近日與廣東天普生化醫藥股份有限公司(“天普生化”)簽署了2021年~2022年的《年度採購框架合同》(“採購合同”),每年度交易金額不低於2億人民幣(不含税金額)。合同期內天普生化向艾迪藥業採購烏司他丁粗製品、尤瑞克林粗製品與尿激酶粗製品的每年度交易金額不低於2億人民幣(不含税金額)。

此採購合同為公司日常生產經營活動相關合同,履行期間為2021年~2022年,對公司2020年度的經營業績不產生影響;若此採購合同順利履行,預計會對公司2021年度及2022年度的業績產生積極影響。此採購合同的簽署,有利於進一步穩定雙方良好的戰略合作關係。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account